Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis
BAL lymphocytosis and eosinophilia are associated with ICIP, but their ability to discriminate ICIP from other conditions is modest. BAL immune cell percentages may have prognostic value for 1-year survival, but this likely reflects the morbidity of other pulmonary diseases that require BAL for evaluation.
Authors
- Karthik Suresh (ORCID: https://orcid.org/0000-0003-2920-0949)
- Aung Naing (ORCID: https://orcid.org/0000-0002-4803-8513)
- Jia Wu (ORCID: https://orcid.org/0000-0001-8392-8338)
- David E. Ost (ORCID: https://orcid.org/0000-0001-6351-5552)
- Roberto Adachi (ORCID: https://orcid.org/0000-0002-0146-0768)
- Vickie R. Shannon (ORCID: https://orcid.org/0000-0002-5938-4841)
- Arumugam Suresh (ORCID: https://orcid.org/0000-0001-6247-1156)
- Roberto F. Casal (ORCID: https://orcid.org/0000-0002-6167-475X)
- Qiong Gan (ORCID: https://orcid.org/0000-0001-6563-5611)
- Lara Bashoura (ORCID: https://orcid.org/0000-0003-1126-4039)
- Mehmet Altan (ORCID: https://orcid.org/0000-0001-9229-156X)
- Diwakar D. Balachandran
- Mahnoor Mir
- Saadia A. Faiz (ORCID: https://orcid.org/0000-0001-7284-3945)
- Julie Qiaojin Lin (ORCID: https://orcid.org/0000-0002-2669-6478)
- Burton F. Dickey (ORCID: https://orcid.org/0000-0002-4780-1847)
- George A. Eapen (ORCID: https://orcid.org/0000-0001-6408-6964)
- Ajay Sheshadri (ORCID: https://orcid.org/0000-0002-8091-0180)
- Jianjun Gao (ORCID: https://orcid.org/0000-0001-6138-4472)
- Horiana B. Grosu (ORCID: https://orcid.org/0000-0003-2384-4268)
- Scott E. Evans (ORCID: https://orcid.org/0000-0003-4503-0644)
- Bruce F. Sabath (ORCID: https://orcid.org/0000-0002-9437-506X)
- Carlos A. Jimenez (ORCID: https://orcid.org/0000-0002-7189-6292)
- Pedro Antonio Amezcua Gomez
- Rodrigo Del Rio Arroyo
- Felipe Soto
- Amber Su
- John Stewart
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Johns Hopkins University (US)
- The University of Texas Health Science Center (US)
- Spanish Oncology Genitourinary Group (ES)
- Texas A&M University (US)
- Tecnológico de Monterrey (MX)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-06-02
- DOI
- https://doi.org/10.3389/fmed.2025.1582714
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.14